Drug Trial Radar · NCT05201638
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
Last checked: Nov 19, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,100
Actual
Start
Jan 12, 2022
Primary completion
Nov 2026
Study completion Oct 2033
Sponsor
- Lead sponsor
- Immunic AGIndustry
- Sponsor type
- Industry
- First posted
- Jan 21, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-2)
Conditions
- Multiple Sclerosis, Relapsing-Remitting
Interventions
IMU-838 tabletsDrug
Patients are randomized to IMU-838 or placebo in ratio 1:1
Placebo matching IMU-838 tabletsDrug
Patients are randomized to IMU-838 or placebo in ratio 1:1
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate efficacy of IMU-838 versus placebo based on time to first relapseTime frame: 72 weeks
Locations
101 sites in 14 countries. Site status is shown where the registry gives one.
Neuro of Central Florida
Altamonte Springs, Florida
Healthcare Innovations
Coral Springs, Florida
Heratsi Hospital Complex 1
Yerevan, Armenia
Saint Gregory the Illuminator Medical Center
Yerevan, Armenia
Erebouni Medical Center
Yerevan, Armenia
UCC of Rep of Srpska
Banja Luka, Bosnia and Herzegovina
Cantonal Hospital Bihac Dr. Irfan Ljubijankic
Bihać, Bosnia and Herzegovina
University Clinical Hospital Mostar
Mostar, Bosnia and Herzegovina
University Clinical Center of Sarajevo
Sarajevo, Bosnia and Herzegovina
University Clinical Center Sarajevo
Sarajevo, Bosnia and Herzegovina
University Clinical Center Tuzla
Tuzla, Bosnia and Herzegovina
Astra Clinic
Tallinn, Estonia
University Hospital Muenster, Institute Translational Neurology dept. Neurology
Münster, Germany
Post-Graduation Institute of Medical Education and Research (PGIMER)
Chandigarh, India
North East Healthcare Pvt Ltd (Marengo Asia Hospitals, Gurugram)
Haryāna, India
Dr Ram Manohar Lohia Institute of Medical Sciences
Lucknow, India
All India Institute of Medical Sciences
New Delhi, India
GB Pant Institute of Postgraduate Medical Education and Research
New Delhi, India
SRI Guru Ram Das Institute of Medical Sciences and Research
Punjābi Bāgh, India
Vasudev Multi-Speciality Hospital
Raipur, India
Hospital Nacional Dos de Mayo
Lima, Peru
NZOZ Novo-Med
Katowice, Poland
NZOZ Wielospecjalistyczna Poradnia Lekarska "Synapsis"
Katowice, Poland
Neuro-Medic Janusz Zbrojkiewicz
Katowice, Poland
NZOZ Neuromed
Lublin, Poland
Indywidualna Praktyka Lekarska prof. Konrad Rejdak
Lublin, Poland
NZOZ Hertmanowskiej
Plewiska, Poland
NZOZ Neuro-Kard
Poznan, Poland
Centrum Medyczne NeuroProtect
Warsaw, Poland
Centrum Med. Ibismed
Zabrze, Poland
Clubul Sanatatii SRL
Campulung Muscel, Romania
Spitalul clinic CF Constanta
Constanța, Romania
Spitalul Judetean de Urgenta Piatra Neamt
Piatra Neamţ, Romania
Aria Clinic SRL
Sibiu, Romania
Arkhangelsk Regional Clinical Hospital
Arkhangelsk, Russia
Kazan State Medical Academy (Polyclinic) / Federal State Budgetary Educational Institution of Supplementary Professional Education "Russian medical academy of continuous professional education" of the Ministry of Health of the Russian Federation
Kazan', Russia
Kuzbass regional clinical hospital n.a. S.V.Belyaev
Kemerovo, Russia
Budgetary Institution of Khanty-Mansiysk Autonomous District-Yugra "Regional Clinical Hospital"
Khanty-Mansiysk, Russia
Federal State Budgetary Educational Institution of Higher Education "Kirov State Medical University" of the Ministry of Healthcare of the Russian Federation
Kirov, Russia
State Budgetary healthcare Institution of Moscow City "City Policlinic 2 of the Healthcare Department of Moscow City"
Moscow, Russia
Showing 40 of 101 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.